KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 121 filers reported holding KYMERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,603,815 | -54.2% | 1,985,886 | -24.2% | 0.00% | -33.3% |
| Q2 2023 | $60,240,904 | -25.4% | 2,620,309 | -3.9% | 0.00% | -40.0% |
| Q1 2023 | $80,795,825 | -43.1% | 2,726,825 | -52.1% | 0.01% | +25.0% |
| Q4 2022 | $142,083,352 | +143.0% | 5,692,442 | +112.0% | 0.00% | 0.0% |
| Q3 2022 | $58,461,000 | -15.5% | 2,685,404 | -23.6% | 0.00% | 0.0% |
| Q2 2022 | $69,199,000 | -21.9% | 3,514,438 | +67.8% | 0.00% | 0.0% |
| Q1 2022 | $88,642,000 | -15.0% | 2,094,561 | +27.6% | 0.00% | -20.0% |
| Q4 2021 | $104,235,000 | +23.3% | 1,641,762 | +14.0% | 0.01% | +25.0% |
| Q3 2021 | $84,572,000 | +30.5% | 1,439,776 | +7.7% | 0.00% | +33.3% |
| Q2 2021 | $64,827,000 | +78.1% | 1,336,646 | +42.7% | 0.00% | +50.0% |
| Q1 2021 | $36,409,000 | +265.8% | 936,915 | +483.6% | 0.00% | +100.0% |
| Q4 2020 | $9,954,000 | – | 160,545 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 639,059 | $37,538,000 | 24.22% |
| BVF INC/IL | 3,180,658 | $186,832,000 | 7.29% |
| Deer IX & Co. Ltd. | 615,895 | $36,178,000 | 3.72% |
| Asymmetry Capital Management, L.P. | 89,071 | $5,232,000 | 3.14% |
| Redmile Group, LLC | 2,793,708 | $164,102,000 | 2.86% |
| SPHERA FUNDS MANAGEMENT LTD. | 359,260 | $21,103,000 | 1.77% |
| CLOUGH CAPITAL PARTNERS L P | 271,000 | $15,919,000 | 0.96% |
| Rock Springs Capital Management LP | 732,927 | $43,052,000 | 0.90% |
| Eagle Health Investments LP | 37,000 | $2,173,000 | 0.69% |
| Avidity Partners Management LP | 514,500 | $30,222,000 | 0.67% |